CAMBRIDGE, Mass.–(BUSINESS WIRE)– Mersana
Therapeutics, Inc., today announced that Anna Protopapas, President
and Chief Executive Officer, will present at the 28th Annual Piper
Jaffray Healthcare Conference at the Lotte New York Palace Hotel on
Wednesday, November 30, 2016, at 12:10 p.m. ET.
About Mersana Therapeutics
Mersana Therapeutics engineers antibody-drug conjugates (ADCs) that
maximize the potential of new and established therapeutic classes.
Mersana is developing, with select pharmaceutical partners, a portfolio
of next-generation Fleximer® ADCs with superior properties not found
with current ADC technologies. The company is also advancing its own
pipeline of Fleximer-ADCs with best-in-class potential to address unmet
needs and improve patient outcomes in multiple oncology indications.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161123005052/en/
Contacts
Media Contact
For Mersana Therapeutics
Paul Kidwell,
617-680-1088
paulkidwell@comcast.net
or
Investors
Contact
Stern Investor Relations, Inc.
Christina
Tartaglia, 212-362-1200
Christina@sternir.com
Source: Mersana Therapeutics, Inc.
Cet article Mersana Therapeutics to Present at the 28th
Annual Piper Jaffray Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.